OGFRP1 and neoplasm: In addition, in our follow-up immune cell-related abundance analysis, it was found that the plasma B cell abundance level in the high-risk group was higher, which was consistent with the study of Zhou et al. (2021), which suggested that the increased expression of OGFRP1 may be one of the reasons for the poor prognosis of patients in the high-risk group of LUAD and may become a focus of tumor immunotherapy-targeting B cells.